You are registered
Go to My Registration
PROGRAM OVERVIEW The primary care setting is crucial for the early detection and management of Alzheimer's disease and mild cognitive impairment. Despite the significant role family physicians play in Alzheimer's care, they may not diagnose many cases until substantial neurodegeneration and loss of independence have already occurred.This session will highlight the importance of timely diagnosis and the evolving landscape of Alzheimer's biomarkers, including cerebrospinal fluid and emerging blood-based biomarkers. Health professionals mainly use current biomarkers, such as amyloid PET scans and cerebrospinal fluid biomarkers, in research and limited clinic settings. But medical experts anticipate their clinical application to increase with the regulatory approval of disease-modifying therapies. Emerging blood-based biomarkers promise to be less invasive and more accessible, potentially transforming clinical practice. The presenter will discuss the ethical implications of biomarker use and the need for a foundational shift in clinical vigilance. By fostering dialogue between primary care and Alzheimer's disease specialists, we aim to enhance early detection, enable timely intervention and improve patient outcomes through a comprehensive approach to Alzheimer's care.LEARNING OBJECTIVESDemonstrate an understanding of the role of family physicians in Alzheimer’s management. Discuss current and emerging biomarkers for Alzheimer’s. Evaluate the clinical utility of blood-based biomarkers. Identify the benefits of timely Alzheimer’s disease diagnosis. INTENDED AUDIENCE Allied health professionalsClinic managers and directorsPhysiciansSPEAKER Yogi Shah, M.D., is board-certified in family medicine and geriatric medicine. Dr. Shah did his geriatric fellowship at the Mayo Clinic with a special focus on the early detection of dementia. He also holds a master’s in public health from Des Moines University and was the 2021 College of Health Sciences Alumni of the Year. Dr. Shah was the chief medical officer and vice president of medical affairs for Broadlawns Medical Center during the COVID-19 pandemic. Before joining Broadlawns’ medical staff, he was the founding associate dean of global health at Des Moines University. Dr. Shah is the medical director for the Centers for Medicare and Medicaid Services’ Guiding an Improved Dementia Experience Model, site principal investigator for the University of Iowa’s Geriatrics Workforce Enhancement Program and board member of the Iowa Chapter of the Alzheimer's Association.REGISTRATION AND FEES IHA member individual rate – $0 Associate member individual rate – $0IHA nonmember individual rate - $0RECORDINGS POLICY IHA will provide recordings only to those who have registered for the program. CONTINUING EDUCATIONIHA Iowa Board of Nursing Provider No. 4 will award 1.0 nursing contact hours for this webinar.
PROGRAM OVERVIEW
The primary care setting is crucial for the early detection and management of Alzheimer's disease and mild cognitive impairment. Despite the significant role family physicians play in Alzheimer's care, they may not diagnose many cases until substantial neurodegeneration and loss of independence have already occurred.
This session will highlight the importance of timely diagnosis and the evolving landscape of Alzheimer's biomarkers, including cerebrospinal fluid and emerging blood-based biomarkers. Health professionals mainly use current biomarkers, such as amyloid PET scans and cerebrospinal fluid biomarkers, in research and limited clinic settings. But medical experts anticipate their clinical application to increase with the regulatory approval of disease-modifying therapies. Emerging blood-based biomarkers promise to be less invasive and more accessible, potentially transforming clinical practice. The presenter will discuss the ethical implications of biomarker use and the need for a foundational shift in clinical vigilance. By fostering dialogue between primary care and Alzheimer's disease specialists, we aim to enhance early detection, enable timely intervention and improve patient outcomes through a comprehensive approach to Alzheimer's care.
LEARNING OBJECTIVES
INTENDED AUDIENCE
SPEAKER
Yogi Shah, M.D., is board-certified in family medicine and geriatric medicine. Dr. Shah did his geriatric fellowship at the Mayo Clinic with a special focus on the early detection of dementia. He also holds a master’s in public health from Des Moines University and was the 2021 College of Health Sciences Alumni of the Year. Dr. Shah was the chief medical officer and vice president of medical affairs for Broadlawns Medical Center during the COVID-19 pandemic. Before joining Broadlawns’ medical staff, he was the founding associate dean of global health at Des Moines University. Dr. Shah is the medical director for the Centers for Medicare and Medicaid Services’ Guiding an Improved Dementia Experience Model, site principal investigator for the University of Iowa’s Geriatrics Workforce Enhancement Program and board member of the Iowa Chapter of the Alzheimer's Association.
REGISTRATION AND FEES
RECORDINGS POLICY
IHA will provide recordings only to those who have registered for the program.
CONTINUING EDUCATION
IHA Iowa Board of Nursing Provider No. 4 will award 1.0 nursing contact hours for this webinar.